Skip to main content
SpringerLink
Log in

Was bedeutet die Vorschlagsliste verordnungsfähiger Arzneimittel (sog.Positivliste) für die Psychopharmakotherapie?

  • Mitteilungen
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. für den Vorstand der Deutschen Gesellschaft für Psychiatrie,Psychotherapie und Nervenheilkunde (DGPPN), , , , , , DE

    J. Fritze & M. Schmauß

  2. für den Vorstand der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), , , , , , DE

    F. Holsboer

Authors
  1. J. Fritze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Schmauß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Holsboer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Prof.Dr. J. Fritze Asternweg 65, D-50259 Pulheim

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fritze, J., Schmauß, M. & Holsboer, F. Was bedeutet die Vorschlagsliste verordnungsfähiger Arzneimittel (sog.Positivliste) für die Psychopharmakotherapie?. Nervenarzt 74, 195–197 (2003). https://doi.org/10.1007/s00115-003-1478-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-003-1478-5

Search

Navigation